70
Participants
Start Date
December 31, 2009
Primary Completion Date
August 31, 2012
Study Completion Date
October 31, 2012
CureXcell
The CureXcell™ dosage form consists of an aseptically-processed activated cell suspension that has been isolated, activated and purified from the peripheral blood of healthy allogeneic donors, by hypo-osmotic shock, using the MacroCure custom closed bag system.
Rambam Health Care Campus, Haifa
Rabin Medical Center, Petah Tikva
Sheba Medical Center, Tel Litwinsky
Lead Sponsor
Macrocure Ltd.
INDUSTRY